Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03857503 · ClinicalTrials.gov registry record
Radiographic Imaging Validation and EvALuation for Angio iFR (ReVEAL iFR)
A clinical trial, sponsored by Volcano Corporation.
- Completed
- Registry status
- 441
- Enrollment target
NCT03857503 is a clinical trial that has completed, run by Volcano Corporation. The registered enrollment target is 441 participants.
The verdict
NCT03857503 has completed, sponsored by Volcano Corporation.
- COMPLETED
- Registry status
- 441 participants
- Enrollment target
Study Summary
The Philips Angio-iFR medical software device is intended to provide information on the functional significance of a coronary artery lesion to provide guidance on diagnostic decisions similar to that obtained through invasive measures of iFR and FFR. The software application uses the vessel geometry obtained from a coronary angiographic image together with a lumped parameter physiological model to provide the associated iFR and FFR estimates.
Interventions
- DIAGNOSTIC_TEST iFR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 441 participants |
| Start Date | 2019-08-01 |
| Est. Completion | 2021-03-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03857503
The ClinicalTrials.gov registry entry for NCT03857503 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 441 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Volcano Corporation, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which iFR is the first listed.
NCT03857503 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03857503 about?
NCT03857503 is a clinical study titled "Radiographic Imaging Validation and EvALuation for Angio iFR (ReVEAL iFR)". The Philips Angio-iFR medical software device is intended to provide information on the functional significance of a coronary artery lesion to provide guidance on diagnostic decisions similar to that obtained through invasive measures of iFR and FFR. The software application uses the vessel geometry...
What is the current status of trial NCT03857503?
This trial is currently completed. The enrollment target is 441 participants. The study started on 2019-08-01. Estimated completion is 2021-03-12.
What interventions are being tested in trial NCT03857503?
The interventions under investigation include: iFR (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03857503?
This trial is sponsored by Volcano Corporation, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.